tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
US Market
RYTM
Rhythm Pharmaceuticals
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Technical Analysis
Historical Prices
New
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Rhythm Pharmaceuticals (RYTM) Stock News & Sentiment

Compare
488 Followers
Promising Phase 3 Results for Setmelanotide in Hypothalamic Obesity Drive Buy Rating
Premium
Ratings
Promising Phase 3 Results for Setmelanotide in Hypothalamic Obesity Drive Buy Rating
8h ago
RYTM
Promising Phase 3 Results for Setmelanotide Boost Rhythm Pharmaceuticals’ Market Potential
Premium
Ratings
Promising Phase 3 Results for Setmelanotide Boost Rhythm Pharmaceuticals’ Market Potential
13h ago
RYTM
Rhythm Pharmaceuticals Announces Positive Phase 3 Trial Results
Premium
Company Announcements
Rhythm Pharmaceuticals Announces Positive Phase 3 Trial Results
14h ago
8K
RYTM
Strategic Positioning and Promising Trials Drive Buy Rating for Rhythm Pharmaceuticals
Premium
Ratings
Strategic Positioning and Promising Trials Drive Buy Rating for Rhythm Pharmaceuticals
7d ago
RYTM
Promising Potential of Rhythm Pharmaceuticals’ Setmelanotide in Treating Hypothalamic Obesity
Premium
Ratings
Promising Potential of Rhythm Pharmaceuticals’ Setmelanotide in Treating Hypothalamic Obesity
8d ago
RYTM
Buy Rating for Rhythm Pharmaceuticals: Strategic Moves in Asia and Promising Setmelanotide Trials Drive Positive Outlook
Premium
Ratings
Buy Rating for Rhythm Pharmaceuticals: Strategic Moves in Asia and Promising Setmelanotide Trials Drive Positive Outlook
15d ago
RYTM
Strategic Advancements and Market Opportunities Drive Buy Rating for Rhythm Pharmaceuticals
Premium
Ratings
Strategic Advancements and Market Opportunities Drive Buy Rating for Rhythm Pharmaceuticals
15d ago
RYTM
More RYTM News >

RYTM News on the Web

TD Cowen Keeps Their Buy Rating on Rhythm Pharmaceuticals (RYTM)
TipRanks News
Neutral
Rhythm Pharmaceuticals (RYTM) Achieves Success in Phase 3 Obesity Trial
GuruFocus News
Bullish
Rhythm Pharmaceuticals Plans Regulatory Filings After Positive Imcivree Trial Results
GuruFocus News
Bullish
Rhythm Pharmaceuticals (RYTM) Reports Promising Phase 3 Trial Results
GuruFocus News
Bullish
Rhythm Pharmaceuticals Announces Positive Phase 3 Trial Results for Setmelanotide in Treating ...
GuruFocus News
Bullish
Rhythm Pharmaceuticals Inc (RYTM) Announces Conference Call for Phase 3 TRANSCEND Trial Results
GuruFocus News
Neutral
Rhythm Pharmaceuticals Announces Conference Call for Phase 3 TRANSCEND Trial Results
GuruFocus News
Neutral
Roku, Tesla among Q2 Tactical Ideas at Wells Fargo
The Fly
Neutral

News Score - Last 7 Days

Neutral
RYTM
Sector Average
Media Buzz
This Week8 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RYTM’s Media Buzz Sentiment?
8 articles about RYTM were published this week. In an average week, 2 articles are published.
    What is RYTM’s weekly average amount of articles?
    In an average week, 2 articles about RYTM are published.
      What is RYTM’s News Sentiment?
      100% of articles about RYTM were positive this week, compared to its sector average of 62%.
        Healthcare Stocks that are Trending in the News
        RYTMRhythm Pharmaceuticals
        GRIGRI Bio
        SLPSimulations Plus
        BRKRBruker
        AMSAmerican Shared Hospital Services
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing